Michael Ashburner
European Bioinformatics Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Ashburner.
Nucleic Acids Research | 2007
Kirill Degtyarenko; Paula de Matos; Marcus Ennis; Janna Hastings; Martin Zbinden; Alan McNaught; Rafael Alcántara; Michael Darsow; Mickaël Guedj; Michael Ashburner
Chemical Entities of Biological Interest (ChEBI) is a freely available dictionary of molecular entities focused on ‘small’ chemical compounds. The molecular entities in question are either natural products or synthetic products used to intervene in the processes of living organisms. Genome-encoded macromolecules (nucleic acids, proteins and peptides derived from proteins by cleavage) are not as a rule included in ChEBI. In addition to molecular entities, ChEBI contains groups (parts of molecular entities) and classes of entities. ChEBI includes an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified. ChEBI is available online at http://www.ebi.ac.uk/chebi/
Nucleic Acids Research | 2008
Midori A. Harris; Jennifer I. Deegan; Amelia Ireland; Jane Lomax; Michael Ashburner; Susan Tweedie; Seth Carbon; Suzanna E. Lewis; Christopher J. Mungall; John Richter; Karen Eilbeck; Judith A. Blake; Alexander D. Diehl; Mary E. Dolan; Harold Drabkin; Janan T. Eppig; David P. Hill; Ni Li; Martin Ringwald; Rama Balakrishnan; Gail Binkley; J. Michael Cherry; Karen R. Christie; Maria C. Costanzo; Qing Dong; Stacia R. Engel; Dianna G. Fisk; Jodi E. Hirschman; Benjamin C. Hitz; Eurie L. Hong
The Gene Ontology (GO) project (http://www.geneontology.org/) provides a set of structured, controlled vocabularies for community use in annotating genes, gene products and sequences (also see http://www.sequenceontology.org/). The ontologies have been extended and refined for several biological areas, and improvements to the structure of the ontologies have been implemented. To improve the quantity and quality of gene product annotations available from its public repository, the GO Consortium has launched a focused effort to provide comprehensive and detailed annotation of orthologous genes across a number of ‘reference’ genomes, including human and several key model organisms. Software developments include two releases of the ontology-editing tool OBO-Edit, and improvements to the AmiGO browser interface.
Genome Biology | 2005
Jonathan Bard; Seung Y. Rhee; Michael Ashburner
We describe an ontology for cell types that covers the prokaryotic, fungal, animal and plant worlds. It includes over 680 cell types. These cell types are classified under several generic categories and are organized as a directed acyclic graph. The ontology is available in the formats adopted by the Open Biological Ontologies umbrella and is designed to be used in the context of model organism genome and other biological databases. The ontology is freely available at http://obo.sourceforge.net/ and can be viewed using standard ontology visualization tools such as OBO-Edit and COBrA.
Genome Biology | 2010
Christopher J. Mungall; Georgios Vasileios Gkoutos; Cynthia L. Smith; Melissa Haendel; Suzanna E. Lewis; Michael Ashburner
Phenotype ontologies are typically constructed to serve the needs of a particular community, such as annotation of genotype-phenotype associations in mouse or human. Here we demonstrate how these ontologies can be improved through assignment of logical definitions using a core ontology of phenotypic qualities and multiple additional ontologies from the Open Biological Ontologies library. We also show how these logical definitions can be used for data integration when combined with a unified multi-species anatomy ontology.
PLOS Biology | 2009
Nicole L. Washington; Melissa Haendel; Christopher J. Mungall; Michael Ashburner; Monte Westerfield; Suzanna E. Lewis
A novel method for quantifying the similarity between phenotypes by the use of ontologies can be used to search for candidate genes, pathway members, and human disease models on the basis of phenotypes alone.
Nature | 2000
Alvis Brazma; Alan Robinson; Graham Cameron; Michael Ashburner
Is a universal, public DNA-microarray database a realistic goal?
Current Opinion in Structural Biology | 2000
Suzanna E. Lewis; Michael Ashburner; Martin G. Reese
The Genome Annotation Assessment Project tested current methods of gene identification, including a critical assessment of the accuracy of different methods. Two new databases have provided new resources for gene annotation: these are the InterPro database of protein domains and motifs, and the Gene Ontology database for terms that describe the molecular functions and biological roles of gene products. Efforts in genome annotation are most often based upon advances in computer systems that are specifically designed to deal with the tremendous amounts of data being generated by current sequencing projects. These efforts in analysis are being linked to new ways of visualizing computationally annotated genomes.
Human Mutation | 2000
Heikki Lehväslaiho; Elia Stupka; Michael Ashburner
The sequence variation project at EBI aims to create a unified resource for browsing and searching sequence differences. Technical advances in reading in new data types and in validating and cross‐referencing entries are reported. It is suggested that the hardest problems in unifying mutation databases are related to intellectual property rights. The concept of copylefting is introduced as a potential solution to these. Hum Mutat 15:52–56, 2000.
Trends in Ecology and Evolution | 2007
Paula M. Mabee; Michael Ashburner; Quentin C. B. Cronk; Georgios V. Gkoutos; Melissa Haendel; Erik Segerdell; Christopher J. Mungall; Monte Westerfield
Science | 2001
Richard J. Roberts; Harold E. Varmus; Michael Ashburner; Patrick O. Brown; Michael B. Eisen; Chaitan Khosla; Marc W. Kirschner; Roel Nusse; Matthew P. Scott; Barbara J. Wold